<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>34(1)</volume><submitter>Skolnik N</submitter><pubmed_abstract>Primary care clinicians play a key role in asthma and asthma exacerbation management worldwide because most patients with asthma are treated in primary care settings. The high burden of asthma exacerbations persists and important practice gaps remain, despite continual advances in asthma care. Lack of primary care-specific guidance, uncontrolled asthma, incomplete assessment of exacerbation and asthma control history, and reliance on systemic corticosteroids or short-acting beta&lt;sub>2&lt;/sub>-agonist-only therapy are challenges clinicians face today with asthma care. Evidence supports the use of inhaled corticosteroids (ICS) + fast-acting bronchodilator treatments when used as needed in response to symptoms to improve asthma control and reduce rates of exacerbations, and the symptoms that oc</pubmed_abstract><journal>NPJ primary care respiratory medicine</journal><pagination>39</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11570618</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Best practice advice for asthma exacerbation prevention and management in primary care: an international expert consensus.</pubmed_title><pmcid>PMC11570618</pmcid><pubmed_authors>Brunton S</pubmed_authors><pubmed_authors>Skolnik N</pubmed_authors><pubmed_authors>Vazquez MMM</pubmed_authors><pubmed_authors>Winders T</pubmed_authors><pubmed_authors>Barnard A</pubmed_authors><pubmed_authors>Wright WL</pubmed_authors><pubmed_authors>Ulrich A</pubmed_authors><pubmed_authors>Yawn BP</pubmed_authors><pubmed_authors>Correia de Sousa J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Best practice advice for asthma exacerbation prevention and management in primary care: an international expert consensus.</name><description>Primary care clinicians play a key role in asthma and asthma exacerbation management worldwide because most patients with asthma are treated in primary care settings. The high burden of asthma exacerbations persists and important practice gaps remain, despite continual advances in asthma care. Lack of primary care-specific guidance, uncontrolled asthma, incomplete assessment of exacerbation and asthma control history, and reliance on systemic corticosteroids or short-acting beta&lt;sub>2&lt;/sub>-agonist-only therapy are challenges clinicians face today with asthma care. Evidence supports the use of inhaled corticosteroids (ICS) + fast-acting bronchodilator treatments when used as needed in response to symptoms to improve asthma control and reduce rates of exacerbations, and the symptoms that oc</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-04T00:47:53.884Z</modification><creation>2025-04-04T00:47:53.884Z</creation></dates><accession>S-EPMC11570618</accession><cross_references><pubmed>39551807</pubmed><doi>10.1038/s41533-024-00399-2</doi></cross_references></HashMap>